Ibáñez MN, López GCJ, Piña LB

Language: Spanish
References: 24
Page: 56-60
PDF size: 236.74 Kb.

ABSTRACT

The saliva is one of the fluids that help to support the health, exist multiple factors that influence the salivary secretion; at the decrease one the mouth cavity is named xerostomia, which favors the deterioration of the mouth health. The xerostomia is not a disease but a sign that they present multitude of reasons, which can be reversible or irreversible, of your identification depends the indicated treatment. Material and Methods: A retrospective study was realized. There were checked the Clinical Histories of geriatric patients; the necessary information was gathered, tests of independence were realized between these variables. Results: There ware checked a whole of 120 processes of this 56 % it was possessing the result of the sialometría, 42 % presented xerostomia, relation man: women of 1:3.7. from the patients with xerostomia, 25 (89 %) presented some systemic disease and 27 (96 %) they were under pharmacological treatment. Discussion: The frequency of xerostomia in adult major patients ranges between 30 and 79 %, the reports indicate us that the patients geriatric are a capable population since on them they converge several of the factors that favor the xerostomia, which is generated to a great extent as response to the use of medicines.

REFERENCES

1. De Almeida P. del V., Grégio AM, Brancher JA, Ignácio SA, Machado MA, de Lima AA, Azevedo LR. Effects of antidepress ants and benzodiazepines on stimulated salivary flow rate and biochemistry composition of the saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:58-65.

2. Bagán JV, Ceballos A, Bermejo A, Aguirre JM, Peñarrocha M. Medicina Oral. Masson Barcelona, España 1995.

3. Mosqueda Taylor. Tópicos selectos de Oncología Bucal. Planeación y desarrollo editorial. México, D.F. 2007.

4. Bascones A, Tenovuo J, Ship J, Turner M, Mac–Veigh I, López-Ibor JM, Lanzos E, Aliaga A. Conclusiones del Simposium 2007 de la Sociedad Española de Medicina Oral sobre “Xerostomía. Síndrome de Boca Seca. Boca Ardiente”. Av Odontoestomatol 2007; 23 (3): 119-126.

5. Silvestre FJ, Minués MP, Suñe Negre JM. Clinical evaluation of a new artificial saliva in spray form for patients with dry mouth. Med Oral Pathol Pral Cir Bucal 2009;14:E8-11.

6. Rodríguez EH, Sacsaquispe S.J. Tasa de flujo salival y nivel de confort al emplear saliva artificial y caramelos de menta sin azúcar en adultos mayores con xerostomía. Rev Estomatol Herediana 2006; 16(2): 103-109.

7. Mosqueda A, Luna K, Irigoyen ME, Díaz MA, Coll AM. Effect of pilocarpine hydrochoride on salivary production in previously irradiated head and neck cancer patients. Med Oral 2004; 9: 204-11.

8. Olver I. Xerostomía: a common adverse effect of drugs and radiation. Aust Prescr 2006; 29: 97-98.

9. Valicena M, Escalona LA. Manejo Terapéutico del paciente con xerostomía. Acta Odontol 2001; 39 (1).

10. Avcu N, Ozbek M, Kurtoglu D, Kurtoglu E, Kansu O, Kansu H. Oral findings and health status among hospitalized patients with physical disabilities, aged 60 or above. Arch Gerontol Geriatr. 2005;41(1):69-79.

11. Murray T, Herenia P, Broadbent, Poulton R. The impact of xerostomia on oral-health-related quality of life among younger adults. Health and Quality Life Outcomes 2006; 4:86.

12. Turner MD, Ship JA. Dry mounth and its effect on the oral health of elderly people. J Am Dent Assoc 2007;138 (Suppl 1):15S-20S (Erratum in: J Am Dent Assoc 2008;139:252-253).

13. Johansson AK, Johansson A, Unell L, Ekbäck G, Ordell S, Carlsson GE. A 15-yr longitudinal study of xerostomia in a Swedish population of 50-yr-old subjects. Eur J Oral Sci 2009;117:13-19.

14. Formiga F, Mascaró J, Vidaller A, Pujol R. Xerostomía en el paciente anciano. Rev Mult Gerontol 2003;13(1):24-28.

15. Murray Thomson W, Chalmers JM, John Spencer A, Slade GD, Carter KD. Gerodontology. A longitudinal study of medication exposure and xerostomia among older people. 2006 Dec;23(4):205-13.

16. Gallagher L, Naidoo P. Prescription Drugs and Their Effects on Swallowing. Dysphagia 2008 Dec 16. DOI 10.10 07/s0 0455-008-9187-7.

17. Bernardi R, Perin C, Becker F.L, Ramos G.Z, Gheno G.Z, Lopes L.R, Pires M, Barros H.M.T. Effect of pilocarpine moutwash on salivary flow. Braz J Med Biol Res 2002, 35(1): 105-110.

18. Chitapanarux I, Kamnerdsupaphon P, Tharavichitkul E, et al. Effect of oral pilocarpine on post-irradiation xerostomia in head and neck cancer patients: a single-center, single-blind clinical trial. J Med Assoc Thai. 2008 Sep;91(9):1410-5.

19. Aíslan A, Orhan K, Canpolat C, Delilbasi C, Dural S. Impact of xerostomia on oral complaints in a group of elderly Turkish removable denture wearers. Arch Gerontol Geriatr 2008 Nov 12.

20. Espitia S, Castillo L, Carbonell B, Mórelo AP, Pacheco M. Asociación entre la disminución de los niveles de flujo salival y xerostomía en pacientes con insuficiencia renal crónica hemodializados de la unidad renal nefrología LTDA, de la Ciudad de Santa Marta. Duazary 2007; 4(2): 100-7.

21. Fernández RG, Cortés NZ, Ochoa FJ, Poitevin MA, Pérez HE. Respuesta terapéutica de la pilocarpina en relación a la xerostomía inducida por radioterapia. Revista Odontológica Mexicana 2008; 12(3): 149-53.

22. Hargitai I, Sherman R, Strother J. The effects of electrostimulation on parotid saliva flow: A pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 316-20.

23. Guggenheimer J, Moore P. Xerostomia, Etiology, recognition and treatment. J Am Dent Assoc 2003; 134(1): 61-69.

24. Chilenos E, Marques MS. Boca ardiente y saliva. Med Oral 2002; 7(4): 244-53.